Thermo Fisher Scientific Receives European Commission Approval For Proposed Acquisition Of Clario
3/20/2026
Impact: 75
Healthcare
Thermo Fisher Scientific has received approval from the European Commission for its proposed acquisition of Clario. This strategic move is expected to enhance Thermo Fisher's capabilities in the life sciences sector. The approval marks a significant step in the acquisition process, which aims to strengthen Thermo Fisher's market position.
AI summary, not financial advice
Share: